Related Experiment Video
Updated: Aug 15, 2025

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
Published on: June 16, 2022
Prebiotic Activity of Vaginal Lactobacilli on Bifidobacteria: from Concept to Formulation
Barbara Giordani1, Angela Abruzzo1, Carola Parolin1
1Department of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Insights
Vaginal lactobacilli cell-free supernatants stimulate infant gut bifidobacteria growth, particularly from Limosilactobacillus vaginalis BC17. This offers a promising strategy to improve infant gut microbiota, especially for C-section born babies.
Area of Science:
- Microbiology
- Gastroenterology
- Pediatrics
Background:
- Infant gut colonization by Bifidobacterium spp. is crucial for preventing gastrointestinal disorders and immune system maturation.
- Cesarean section (C-section) birth is associated with reduced Bifidobacterium colonization and increased risk of gut issues.
- Maternal vaginal microbiota, rich in lactobacilli, influences infant gut microbiome development.
Purpose of the Study:
- To investigate the bifidogenic activity of cell-free supernatants (CFSs) from vaginal lactobacilli species.
- To assess the impact of these CFSs on the planktonic growth and biofilm formation of infant gut Bifidobacterium strains.
- To evaluate the potential of a CFS formulation for enhancing infant gut Bifidobacterium colonization.
Main Methods:
- CFSs were obtained from Lactobacillus crispatus, Lactobacillus gasseri, Limosilactobacillus vaginalis, and Lactiplantibacillus plantarum after varying fermentation times.
- The ability of CFSs to stimulate planktonic growth and biofilm formation of Bifidobacterium strains was evaluated.
- An intestinal Escherichia coli strain was used as a control to assess specificity.
- A CFS from L. vaginalis BC17 was formulated into a hyaluronic acid-based hydrogel.
Main Results:
- All tested CFSs demonstrated bifidogenic effects, with maximal activity observed in CFSs recovered during the exponential growth phase.
- CFSs from L. vaginalis BC17 exhibited the strongest bifidogenic profile, significantly increasing Bifidobacterium planktonic growth (up to 432%) and biofilm formation (up to 289%).
- No stimulating effect was observed on the control Escherichia coli strain, indicating specificity.
- The L. vaginalis BC17 CFS formulation maintained its bifidogenic activity.
Conclusions:
- Cell-free supernatants from vaginal lactobacilli, particularly Limosilactobacillus vaginalis BC17, effectively promote the growth and biofilm formation of Bifidobacterium spp.
- These CFSs represent a safe and potentially ecosustainable strategy to enhance Bifidobacterium colonization in infants, especially those born via C-section.
- The successful formulation of L. vaginalis BC17 CFS into a hydrogel highlights its therapeutic potential for both maternal and infant gut health.
Abstract:
The gut of babies born vaginally is rapidly colonized by Bifidobacterium spp. after birth, while in infants born by cesarean section (C-section), the presence of bifidobacteria drops dramatically, increasing the risk of developing gastrointestinal disorders. Considering that newborns naturally come into contact with maternal lactobacilli as they pass through the birth canal, the aim of this work is to exploit for the first time the bifidogenic activity exerted by the cell-free supernatants (CFSs) from lactobacilli of vaginal origin, belonging to the species Lactobacillus crispatus, Lactobacillus gasseri, Limosilactobacillus vaginalis, and Lactiplantibacillus plantarum. CFSs were recovered after 7 h, 13 h, and 24 h of fermentation and assessed for the ability to stimulate the planktonic growth and biofilms of Bifidobacterium strains belonging to species widely represented in the gut tract. A bifidogenic effect was observed for all CFSs; such activity was maximal for CFSs recovered in exponential phase and was strongly dependent on the species of lactobacilli. Importantly, no stimulating effects on an intestinal Escherichia coli strain were observed. CFSs from L. vaginalis BC17 showed the best bifidogenic profile since they increased bifidobacterial planktonic growth by up to 432% and biofilm formation by up to 289%. The CFS at 7 h from BC17 was successfully formulated with a hyaluronic acid-based hydrogel aimed at preventing and treating breast sores in lactating women and exerting bifidogenic activity in infants born mainly by C-section. IMPORTANCE Bifidobacteria in the gut tract of infants play crucial roles in the prevention of gastrointestinal diseases and the maturation of the immune system. Consequently, strategies to trigger a bifidogenic shift in the infant gut are highly desirable. Evidences suggest that the presence of a maternal vaginal microbiota dominated by health-promoting lactobacilli and the development of a bifidobacterium-enriched gut microbiota in newborns are interconnected. In this context, we found out that the cell-free supernatants from lactobacilli of vaginal origin were able to effectively stimulate the proliferation of Bifidobacterium spp. grown in free-floating and biofilm forms. The cell-free supernatant from Limosilactobacillus vaginalis BC17 showed excellent bifidogenic behavior, which was preserved even after its incorporation into a nipple formulation for lactating women. Lactobacilli derivatives, such as cell-free supernatants, have gained increasing interest by virtue of their safer profile than that of living cells and can be proposed as an ecosustainable approach to favor gut colonization of infants by bifidobacteria.
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Vagina
Bacterial Phylum Firmicutes
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Bacterial Phylum Verrucomicrobiota

